LifeStance Health Group, Inc. (LFST) Q3 2026 earnings results
LifeStance Health Group, Inc. (LFST) reported Q3 2026 results on Nov 4, 2026, 7:56:41 PM ET: GAAP EPS $0.06 vs. $0.08 expected (miss by 28.5%); revenue $455.86M vs. $431.58M expected (beat by 5.6%). Outlook: The company expects Q4 2026 revenue of $446 million to $466 million.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | $0.06 | $0.08 | Miss by 28.5% |
| Revenue | $455.86M | $431.58M | Beat by 5.6% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 4, 2026, 7:56:41 PM ET. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 25.3% from $363.81M.
Stock reaction
The results came out after the market closed. LFST closed at $13.43 on November 5, 2026, down 5.5% from its $14.21 close on November 4, 2026 before the results. Latest: $14.48 as of 11:45 AM ET, +1.9% since the pre-release close.
Questions and answers
Did LifeStance Health Group, Inc. beat earnings expectations?
No. LifeStance Health Group, Inc. reported GAAP EPS of $0.06 against an average analyst estimate of $0.08 (miss by 28.5%), and revenue of $455.86M against $431.58M expected (beat by 5.6%).
What were LifeStance Health Group, Inc.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of $0.06 and revenue of $455.86M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 25.3% from $363.81M.
When did LifeStance Health Group, Inc. report Q3 2026 earnings?
Nov 4, 2026, 7:56:41 PM ET, in an SEC 8-K filing (Item 2.02).
How did LFST stock react to the earnings?
The results came out after the market closed. LFST closed at $13.43 on November 5, 2026, down 5.5% from its $14.21 close on November 4, 2026 before the results. Latest: $14.48 as of 11:45 AM ET, +1.9% since the pre-release close.
What did LifeStance Health Group, Inc. say about its outlook?
The company expects Q4 2026 revenue of $446 million to $466 million.
More on LFST
LFST stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 4, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:45 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:45 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt